Friday, December 15, 2023 9:50:57 AM
YUUUUUUUUUUPPPPPP
Recent RPHM News
- Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update • GlobeNewswire Inc. • 03/28/2024 11:35:00 AM
- Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors • GlobeNewswire Inc. • 03/25/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:00:15 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/05/2024 09:01:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 02:26:00 PM
- Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM) • GlobeNewswire Inc. • 12/14/2023 02:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/22/2023 05:15:05 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/13/2023 10:08:12 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/13/2023 09:58:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:05:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:00:11 PM
- Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/13/2023 12:35:00 PM
- Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/02/2023 11:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:47:24 PM
- Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings • GlobeNewswire Inc. • 10/25/2023 11:50:00 AM
- Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM) • GlobeNewswire Inc. • 10/09/2023 11:50:00 AM
- Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit • GlobeNewswire Inc. • 10/06/2023 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 09:04:03 PM
- Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 08/29/2023 11:35:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/28/2023 09:33:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:01:45 PM
- Reneo Pharmaceuticals Reports Second Quarter 2023 Financial Results • GlobeNewswire Inc. • 08/10/2023 11:35:00 AM
- Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics Forum • GlobeNewswire Inc. • 06/30/2023 12:25:00 PM
- Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® Indices • GlobeNewswire Inc. • 06/26/2023 12:25:00 PM
- Reneo Pharmaceuticals Announces Presentation and Posters at Mitochondrial Medicine Symposium 2023 • GlobeNewswire Inc. • 06/15/2023 04:44:29 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM